Brief: Pacific Biosciences Announces Record Orders In Q4 2022

Pacific Biosciences of California

09/01/2023 13:32

Jan 9 (Reuters) - Pacific Biosciences of California Inc
 PACB.O :
    * PACBIO ANNOUNCES RECORD ORDERS, INCLUDING ORDERS FOR 76
REVIO
SYSTEMS RECEIVED IN THE FOURTH QUARTER OF 2022
    * PACIFIC BIOSCIENCES OF CALIFORNIA -EXPECT PRELIMINARY
UNAUDITED
Q4 REVENUE OF ABOUT $27.3 MILLION, A DECREASE OF ABOUT 24%
COMPARED WITH $36.0 MILLION FOR Q4 2021
    * PACIFIC BIOSCIENCES OF CALIFORNIA - PRELIMINARY UNAUDITED
ANNUAL
2022 REVENUE IS EXPECTED TO BE ABOUT $128.2 MILLION,
REPRESENTING  DECLINE OF 2% FROM 2021

Source text for Eikon:  ID:nPn8mRtXpa 
Further company coverage:  PACB.O 
 ((Reuters.Briefs@thomsonreuters.com;))